Date published: 2026-4-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

GRK 2 Inhibitors

GRK 2 inhibitors belong to a chemical class of compounds designed to selectively target and inhibit the function of G protein-coupled receptor kinase 2 (GRK 2), an enzyme that plays a crucial role in regulating G protein-coupled receptor (GPCR) signaling. GPCRs are a large family of cell membrane receptors that are involved in transmitting signals from various extracellular molecules to the inside of the cell, influencing a wide range of physiological processes. GRK 2 is a member of the GRK family and is known to phosphorylate and desensitize activated GPCRs, leading to the attenuation of GPCR signaling and preventing prolonged cellular responses. Inhibiting GRK 2 aims to interfere with its ability to phosphorylate and desensitize GPCRs, resulting in altered GPCR signaling and downstream cellular responses. By modulating the function of GRK 2, these inhibitors influence various cellular processes that are mediated by GPCR signaling pathways. The development of GRK 2 inhibitors offers a way to study the specific functions and molecular interactions of GRK 2, shedding light on its role in regulating GPCR signaling and cellular responsiveness. Understanding the intricate mechanisms by which GRK 2 operates can provide insights into cellular communication and signaling pathways that may have broader implications for scientific research.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

βARK1 Inhibitor Inhibitor

24269-96-3sc-221268
5 mg
$254.00
4
(1)

βARK1 Inhibitor functions as a selective modulator of G protein-coupled receptor kinase 2 (GRK2), influencing receptor desensitization and signaling pathways. Its unique binding affinity allows it to stabilize specific conformations of GRK2, thereby altering its interaction with substrates. This compound exhibits distinct kinetic properties, promoting a nuanced regulation of downstream signaling cascades, which can lead to varied cellular responses. Its structural characteristics facilitate targeted engagement with GRK2, enhancing its role in cellular signaling dynamics.

Paroxetine

61869-08-7sc-507527
1 g
$180.00
(0)

Paroxetine is an antidepressant that might inhibit GRK2 by interfering with its activity, potentially modulating G protein-coupled receptor (GPCR) signaling.

Compound 101

161125-36-6sc-507528
5 mg
$108.00
(0)

Compound 101 is a potential GRK2 inhibitor that might impact its kinase activity, potentially affecting GPCR signaling and cellular responses.

(-)-trans-4-[4-(4′-Fluorophenyl)-3-piperidinylmethoxy]-2-methoxyphenol(Paroxetine metabolite)

112058-90-9sc-213088
5 mg
$380.00
(0)

A metabolite of paroxetine, the antidepressant, that might also inhibit GRK2 and modulate GPCR signaling pathways.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol is a beta-blocker that might inhibit GRK2 by modulating GPCR signaling pathways and cellular responses.

Pindolol

13523-86-9sc-204847
sc-204847A
100 mg
1 g
$194.00
$760.00
(1)

Pindolol is a non-selective beta-blocker that might inhibit GRK2 by affecting GPCR signaling pathways and cellular responses.